News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Benjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center

Articles by Benjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Chemotherapy-TKI Combinations in Metastatic EGFR+ Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

TKI Combinations in Metastatic EGFR+ Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Role of Adjuvant Osimertinib in Early Stage NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

ADAURA Trial; Early Stage Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Trending on OncLive

Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC

FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC

Rocbrutinib Displays Durable Activity in Covalent BTK Inhibitor–Pretreated R/R MCL

FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma

Risvutatug Rezetecan Shows OS Benefit Over Topotecan in Relapsed SCLC